Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ACBMACRO BIOMEDICAL CO., LTD.

OTC · CIK 0001622996
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC7900 Services-Amusement & Recreation Services
FY end1231
XBRL facts149

Identity from submissions API

NameACRO BIOMEDICAL CO., LTD.
CIK0001622996
TickersACBM
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC7900 Services-Amusement & Recreation Services
EIN471950356
LEI—
Fiscal year end1231
State of incorporationNV NV
Phone(317) 286-6788
Website—
Investor website—
Owner org07 Trade & Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • KILLER WAVES HAWAII, INC (2014-10-23T04:00:00.000Z → 2017-01-30T05:00:00.000Z)
Business address
12175 VISIONARY WAY
SUITE 1160
FISHERS
IN
46038
IN
Mailing address
12175 VISIONARY WAY
SUITE 1160
FISHERS
IN
46038
IN

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

92 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 NT 10-Q NT 10-Q 0001640334-26-001824 000-55643 261562348 34 31289
2026-09-02 8-K FORM 8-K 5.02 0001640334-26-001447 000-55643 261354739 34 124396 1 1
2026-08-14 10-Q FORM 10-Q 0001640334-26-001345 000-55643 261275504 34 1399475 1 1
2026-05-05 10-Q FORM 10-Q 0001640334-26-000824 000-55643 26942591 34 1260763 1 1
2026-02-11 10-K FORM 10-K 0001640334-26-000241 000-55643 26619551 34 2006906 1 1
2026-01-08 8-K FORM 8-K 4.01,9.01 0001640334-26-000053 000-55643 26517117 34 138828 1 1
2025-11-10 10-Q FORM 10-Q 0001640334-25-001999 000-55643 251466622 34 1564205 1 1
2025-08-14 8-K FORM 8-K 5.02 0001640334-25-001486 000-55643 251217213 34 121796 1 1
2025-08-05 10-Q FORM 10-Q 0001640334-25-001347 000-55643 251182769 34 1636555 1 1
2025-07-24 10-Q FORM 10-Q 0001640334-25-001302 000-55643 251147946 34 1471987 1 1
2025-07-24 10-K FORM 10-K 0001640334-25-001300 000-55643 251147917 34 2382345 1 1
2025-07-23 10-Q FORM 10-Q 0001640334-25-001281 000-55643 251142754 34 1817408 1 1
2025-07-23 10-Q FORM 10-Q 0001640334-25-001279 000-55643 251142736 34 1704117 1 1
2025-07-22 10-Q FORM 10-Q 0001640334-25-001257 000-55643 251140243 34 1568082 1 1
2025-07-18 10-K FORM 10-K 0001640334-25-001245 000-55643 251135242 34 2576945 1 1
2025-07-11 10-Q FORM 10-Q 0001640334-25-001169 000-55643 251117725 34 2069647 1 1
2025-07-02 8-K FORM 8-K 4.01,9.01 0001640334-25-001097 000-55643 251098083 34 133225 1 1
2023-11-15 NT 10-Q FORM 12B-25 0001640334-23-002178 000-55643 231411511 34 22876
2023-08-14 10-Q FROM 10-Q 0001640334-23-001563 000-55643 231168775 34 1888348 1 1
2023-08-02 10-Q FORM 10-Q 0001640334-23-001422 000-55643 231134641 34 1735036 1 1
2023-07-21 10-K FORM 10-K 0001640334-23-001347 000-55643 231101940 34 2543924 1 1
2023-04-03 NT 10-K FORM NT 10-K 0001640334-23-000544 000-55643 23793917 34 26457
2022-11-21 10-Q FORM 10-Q 0001640334-22-002503 000-55643 221405636 34 2010370 1 1
2022-11-14 NT 10-Q FORM 12B-25 0001640334-22-002449 000-55643 221384317 34 25171
2022-08-12 10-Q FORM 10-Q 0001640334-22-001752 000-55643 221160352 34 1888717 1 1
2022-05-16 10-Q FORM 10-Q 0001640334-22-001037 000-55643 22927126 34 1702283 1 1
2022-04-15 10-K FORM 10-K 0001640334-22-000809 000-55643 22829950 34 2428576 1 1
2022-04-01 NT 10-K FORM NT 10-K 0001640334-22-000697 000-55643 22796369 34 26802
2021-11-22 10-Q FORM 10-Q 0001640334-21-002942 000-55643 211431896 34 1970886 1 1
2021-11-16 NT 10-Q NT 10-Q 0001640334-21-002869 000-55643 211415808 34 22934
2021-08-23 10-Q FORM 10-Q 0001640334-21-002018 000-55643 211196565 34 1789061 1 1
2021-08-17 NT 10-Q NT 10-Q 0001640334-21-001951 000-55643 211182517 34 23581
2021-05-24 10-Q FORM 10-Q 0001640334-21-001236 000-55643 21954229 34 1569291 1
2021-05-17 NT 10-Q NT 10-Q 0001640334-21-001180 000-55643 21930302 34 22656
2021-04-02 10-K FORM 10-K 0001640334-21-000767 000-55643 21802736 34 2284837 1
2021-04-01 NT 10-K NT 10-K 0001640334-21-000748 000-55643 21797844 34 22191
2021-02-26 SC 13D SC 13D 0001640334-21-000454 005-92291 21685917 34 27020
2021-02-26 5 FORM 5 0001640334-21-000453 4269
2020-12-14 S-8 FORM S-8 0001640334-20-003064 333-251333 201386814 33 55594
2020-11-17 10-Q FORM 10-Q 0001640334-20-002867 000-55643 201320978 34 1667814 1
2020-11-17 NT 10-Q NT 10-Q 0001640334-20-002860 000-55643 201320129 34 21864
2020-09-08 10-12G FORM 10-12G 0001640334-20-002297 000-55643 201164834 34 760649
2020-08-19 10-Q FORM 10-Q 0001640334-20-002198 333-207765 201117583 34 1674035 1
2020-08-14 NT 10-Q NT 10-Q 0001640334-20-002106 333-207765 201101124 34 19176
2020-08-13 8-K FORM 8-K 5.02,5.07,9.01 0001640334-20-002068 333-207765 201097061 34 123114
2020-05-19 10-Q FORM 10-Q 0001640334-20-001279 333-207765 20892779 34 1545046 1
2020-05-18 NT 10-Q NT 10-Q 0001640334-20-001257 333-207765 20889079 34 20717
2020-03-27 10-KT FORM 10-K 0001640334-20-000639 333-207765 20751028 34 2393071 1
2020-01-17 8-K FORM 8-K 5.03 0001640334-20-000108 333-207765 20532566 34 10569
2020-01-07 10-K FORM 10-K 0001640334-20-000007 333-207765 20512758 34 1818107 1
2019-12-31 NT 10-K NT 10-K 0001640334-19-002689 333-207765 191318572 34 17350
2019-08-14 10-Q FORM 10-Q 0001640334-19-001630 333-207765 191025361 34 1242259 1
2019-05-15 10-Q FORM 10-Q 0001640334-19-000877 333-207765 19827180 34 1171653 1
2019-02-14 10-Q FORM 10-Q 0001640334-19-000261 333-207765 19607677 34 1028408 1
2018-12-28 10-K FORM 10-K 0001640334-18-002423 333-207765 181256975 34 1723886 1
2018-10-22 8-K FORM 8-K 4.01,9.01 0001640334-18-001967 333-207765 181131810 34 15195
2018-08-14 10-Q FORM 10-Q 0001640334-18-001572 333-207765 181017039 34 978555 1
2018-08-01 10-Q FORM 10-Q 0001640334-18-001489 333-207765 18985739 34 1007366 1
2018-07-06 8-K FORM 8-K 4.01 0001640334-18-001322 333-207765 18942346 34 10992
2018-06-22 8-K FORM 8-K 4.01,9.01 0001640334-18-001249 333-207765 18913209 34 52478
2018-05-16 NT 10-Q NT 10-Q 0001640334-18-001018 333-207765 18839257 34 17223
2018-03-19 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2018-03-19 10:00:00 9999999995-18-000630 333-223046 18700585 33 1803
2018-03-16 S-1/A FORM S-1 AMENDMENT NO. 1 0001640334-18-000466 333-223046 18694192 33 38817
2018-02-15 S-1 FORM S-1 0001640334-18-000339 333-223046 18617560 33 1838296 1
2018-02-14 10-Q FORM 10-Q 0001640334-18-000321 333-207765 18613705 34 1005894 1
2018-01-16 10-K/A FORM 10-K/A 0001640334-18-000103 333-207765 18529160 34 1383552 1
2018-01-16 10-K FORM 10-K 0001640334-18-000094 333-207765 18528583 34 333195
2017-12-29 NT 10-K FORM NT 10-K 0001640334-17-002745 333-207765 171280796 34 16877
2017-08-11 10-Q FORM 10-Q 0001640334-17-001625 333-207765 171024785 34 717765 1
2017-05-22 10-Q FORM 10-Q 0001640334-17-001056 333-207765 17860365 34 758763 1
2017-05-16 NT 10-Q NT 10-Q 0001640334-17-000987 333-207765 17847426 34 18333
2017-05-12 8-K FORM 8-K 4.01,8.01,9.01 0001640334-17-000937 333-207765 17840029 34 15757
2017-02-14 10-Q FORM 10-Q 0001640334-17-000299 333-207765 17608046 34 733419 1
2017-02-01 8-K FORM 8-K 5.01,5.02,5.03,5.07,9.01 0001640334-17-000223 333-207765 17562551 34 786248
2017-01-30 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001640334-17-000098,2017-01-30 9999999995-17-000232 333-207765 17559281 33 1669
2017-01-26 CORRESP filename1.htm 0001640334-17-000177 5982
2017-01-17 UPLOAD filename1.pdf 0000000000-17-001560 42276
2017-01-17 POS AM FORM S-1, POST EFFECTIVE AMENDMENT NO. 1 0001640334-17-000098 333-207765 17528968 33 655774
2016-12-21 POS AM FORM S-1, POST EFFECTIVE AMENDMENT NO. 1 0001640334-16-002273 333-207765 162064256 33 617565
2016-12-16 10-K FORM 10-K 0001640334-16-002238 333-207765 162056862 34 1558696 1
2016-08-03 10-Q FORM 10-Q 0001640334-16-001481 000-55643 161803295 34 930804 1
2016-05-13 10-Q FORM 10-Q 0001640334-16-001061 000-55643 161645946 34 1118881 1
2016-03-02 424B3 PROSPECTUS 0001640334-16-000761 333-207765 161475157 33 750568
2016-02-29 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2016-02-29 17:00:00 9999999995-16-003856 333-207765 161470835 33 1657
2016-02-24 CORRESP filename1.htm 0001640334-16-000741 7504
2016-02-18 S-1/A FORM S-1 AMENDMENT NO. 2 0001640334-16-000716 333-207765 161435740 33 825956
2016-01-14 UPLOAD filename1.pdf 0000000000-16-061422 44717
2015-12-31 CORRESP filename1.htm 0001640334-15-000510 28135
2015-12-31 S-1/A FORM S-1 0001640334-15-000508 333-207765 151315804 33 645874
2015-11-30 UPLOAD filename1.pdf 0000000000-15-055684 173955
2015-11-03 S-1 FORM S-1 0001640334-15-000271 333-207765 151193307 33 2882836
2014-10-23 D xslFormDX01/primary_doc.xml 06b 0001622996-14-000002 021-226991 141168599 33 5756

Latest XBRL company facts

One latest value per concept from companyfacts (149 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 60.04M 2026-08-05 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
dei EntityPublicFloat Entity Public Float USD 21,029 2025-06-30 2025 FY 10-K 2026-02-11 0001640334-26-000241
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 56,000 2026-03-31 2026 Q1 10-Q 2026-05-05 0001640334-26-000824
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 63,050 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 638,500 2022-12-31 2022 FY 10-K 2023-07-21 0001640334-23-001347
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 0 2023-12-31 2023 FY 10-K 2025-07-18 0001640334-25-001245
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 92,227 2018-09-30 2020 FY 10-KT 2020-03-27 0001640334-20-000639
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 32.32M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 32.29M 2021-12-31 2021 FY 10-K 2022-04-15 0001640334-22-000809
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 480,000 2024-12-31 2024 FY 10-K 2025-07-24 0001640334-25-001300
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 480,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-07-24 0001640334-25-001300
us-gaap AmortizationOfDeferredSalesCommissions Amortization of Deferred Sales Commissions USD 7.05M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001640334-23-001563
us-gaap Assets Assets USD 3,648 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap AssetsCurrent Assets, Current USD 3,648 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap Cash Cash USD 322 2023-03-31 2023 Q1 10-Q 2023-08-02 0001640334-23-001422
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 215,494 2021-06-30 2021 Q2 10-Q 2021-08-23 0001640334-21-002018
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 197,371 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-23 0001640334-21-002018
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 3,648 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -450 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD 136,540 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001640334-21-002942
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 100.00M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 60.04M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 60.04M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap CommonStockValue Common Stock, Value, Issued USD 60,042 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap CostOfRevenue Cost of Revenue USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2025-07-18 0001640334-25-001245
us-gaap DeferredCompensationEquity Deferred Compensation Equity USD 0 2023-12-31 2023 FY 10-K 2025-07-18 0001640334-25-001245
us-gaap DeferredCompensationLiabilityCurrent Deferred Compensation Liability, Current USD 19.85M 2022-03-31 2022 Q1 10-Q 2022-05-16 0001640334-22-001037
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -9,871 2018-10-01 2019-06-30 2019 Q3 10-Q 2019-08-14 0001640334-19-001630
us-gaap DeferredRevenue Deferred Revenue USD 20,000 2025-12-31 2025 FY 10-K 2026-02-11 0001640334-26-000241
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap DeferredTaxAssetsLiabilitiesNetNoncurrent Deferred Tax Assets, Net, Noncurrent USD 9,871 2019-06-30 2019 Q3 10-Q 2019-08-14 0001640334-19-001630
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-12-31 2025 FY 10-K 2026-02-11 0001640334-26-000241
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 6.89M 2025-12-31 2025 FY 10-K 2026-02-11 0001640334-26-000241
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 94,241 2017-09-30 2017 FY 10-K/A 2018-01-16 0001640334-18-000103
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 6.89M 2025-12-31 2025 FY 10-K 2026-02-11 0001640334-26-000241
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 4,230 2023-09-30 2023 Q3 10-Q 2025-07-11 0001640334-25-001169
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 4,992 2018-09-30 2019 Q3 10-Q 2019-08-14 0001640334-19-001630
us-gaap DueToOfficersOrStockholdersCurrentAndNoncurrent Due to Officers or Stockholders USD 20,145 2022-06-30 2022 Q2 10-Q 2022-08-12 0001640334-22-001752
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 78,826 2022-12-31 2022 FY 10-K 2023-07-21 0001640334-23-001347
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 78,826 2022-12-31 2022 FY 10-K 2023-07-21 0001640334-23-001347
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.14 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001640334-22-000809
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.07 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001640334-21-002942
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-11 0001640334-26-000241
us-gaap GrossProfit Gross Profit USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2025-07-18 0001640334-25-001245
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -101,146 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-11 0001640334-26-000241
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -854,181 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-23 0001640334-21-002018
us-gaap IncomeLossFromSubsidiariesBeforeTax Income (Loss) from Subsidiaries, before Tax USD -3.93M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001640334-22-001037
us-gaap IncomeTaxCreditsAndAdjustments Income Tax Credits and Adjustments USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001640334-22-001037
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001640334-23-001563
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-11 0001640334-26-000241
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD -18,092 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-02 0001640334-21-000767
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -17,127 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-19 0001640334-20-001279
us-gaap IncomeTaxReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Amount USD 1,922 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-11 0001640334-26-000241
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -21,241 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-11 0001640334-26-000241
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 7,500 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 450 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-05 0001640334-26-000824
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-07-24 0001640334-25-001300
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD -19,156 2019-01-01 2019-12-31 2020 FY 10-K 2021-04-02 0001640334-21-000767
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -17,464 2020-01-01 2020-03-31 2021 Q1 10-Q 2021-05-24 0001640334-21-001236
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD -19,941 2019-01-01 2019-12-31 2020 FY 10-K 2021-04-02 0001640334-21-000767
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001640334-22-000809
us-gaap IncreaseDecreaseInDepositOtherAssets Increase (Decrease) in Deposit Assets USD 370 2023-01-01 2023-12-31 2023 FY 10-K 2025-07-18 0001640334-25-001245
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 3,085 2022-01-01 2022-12-31 2022 FY 10-K 2023-07-21 0001640334-23-001347
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2025-07-11 0001640334-25-001169
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-05 0001640334-26-000824
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -10,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap IncreaseDecreaseInSecurityDeposits Increase (Decrease) in Security Deposits USD 4,600 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-11 0001640334-26-000241
us-gaap InterestAndDebtExpense Interest and Debt Expense USD 22,306 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-07-24 0001640334-25-001302
us-gaap InterestExpense Interest Expense USD 3,206 2023-01-01 2023-12-31 2023 FY 10-K 2025-07-18 0001640334-25-001245
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 1,706 2022-01-01 2022-12-31 2022 FY 10-K 2023-07-21 0001640334-23-001347
us-gaap InterestIncomeRelatedParty Interest Income, Related Party USD 420 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001640334-22-001752
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 0 2017-10-01 2018-03-31 2018 Q2 10-Q 2018-08-01 0001640334-18-001489
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap InventoryNet Inventory, Net USD 296,000 2022-09-30 2022 Q3 10-Q 2022-11-21 0001640334-22-002503
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 2,315 2023-10-30 2023-11-01 2025 Q3 10-Q 2025-11-10 0001640334-25-001999
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 13,890 2025-06-30 2025 Q2 10-Q 2025-08-05 0001640334-25-001347
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 0 2025-06-30 2025 Q2 10-Q 2025-08-05 0001640334-25-001347
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 18,520 2025-03-31 2025 Q1 10-Q 2025-07-24 0001640334-25-001302
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 27,780 2024-09-30 2024 Q3 10-Q 2025-07-23 0001640334-25-001281
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 13,890 2025-06-30 2025 Q2 10-Q 2025-08-05 0001640334-25-001347
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 239 2025-06-30 2025 Q2 10-Q 2025-08-05 0001640334-25-001347
us-gaap Liabilities Liabilities USD 326,946 2024-12-31 2024 FY 10-K 2025-07-24 0001640334-25-001300
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 3,648 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap LiabilitiesCurrent Liabilities, Current USD 448,437 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 59,875 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 58,915 2017-10-01 2018-03-31 2018 Q2 10-Q 2018-08-01 0001640334-18-001489
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -60,325 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 376,106 2017-10-01 2018-03-31 2018 Q2 10-Q 2018-08-01 0001640334-18-001489
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -65,130 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 3,870 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-23 0001640334-21-002018
us-gaap OperatingExpenses Operating Expenses USD 77,825 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -77,825 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 18,520 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-11 0001640334-26-000241
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 13,651 2025-06-30 2025 Q2 10-Q 2025-08-05 0001640334-25-001347
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 0 2025-12-31 2025 FY 10-K 2026-02-11 0001640334-26-000241
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2025-06-30 2025 Q2 10-Q 2025-08-05 0001640334-25-001347
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 0 2025-12-31 2025 FY 10-K 2026-02-11 0001640334-26-000241
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 26,280 2021-12-31 2022 FY 10-K 2023-07-21 0001640334-23-001347
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 26,280 2021-12-31 2022 FY 10-K 2023-07-21 0001640334-23-001347
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 26,280 2022-06-30 2022 Q2 10-Q 2022-08-12 0001640334-22-001752
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 0 2021-12-31 2022 FY 10-K 2023-07-21 0001640334-23-001347
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 13,140 2022-06-30 2022 Q2 10-Q 2022-08-12 0001640334-22-001752
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 33.00M 2025-12-31 2025 FY 10-K 2026-02-11 0001640334-26-000241
us-gaap OtherExpenses Other Expenses USD 1,577 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001640334-23-001563
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 88,796 2023-12-31 2023 FY 10-K 2025-07-18 0001640334-25-001245
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 6,025 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-10 0001640334-25-001999
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 12,695 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 20,000 2018-06-30 2018 Q3 10-Q 2018-08-14 0001640334-18-001572
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 25.00M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap PrepaidRent Prepaid Rent HKD 2,190 2022-12-31 2022 FY 10-K 2023-07-21 0001640334-23-001347
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 500,000 2016-10-01 2017-09-30 2018 FY 10-K 2018-12-28 0001640334-18-002423
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 59,875 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD 10,000 2015-10-01 2016-09-30 2016 FY 10-K 2016-12-16 0001640334-16-002238
us-gaap ProfessionalFees Professional Fees USD 58,405 2017-10-01 2017-12-31 2018 Q1 10-Q 2018-02-14 0001640334-18-000321
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -65,130 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-07-24 0001640334-25-001300
us-gaap ReceivableWithImputedInterestEffectiveYieldInterestRate Receivable with Imputed Interest, Effective Yield (Interest Rate) pure 0.04 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001640334-22-001752
us-gaap RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty Related Party Transaction, Expenses from Transactions with Related Party USD 504 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001640334-22-001752
us-gaap RelatedPartyTransactionRate Related Party Transaction, Rate pure 0.05 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001640334-22-001752
us-gaap RepaymentOfNotesReceivableFromRelatedParties Repayment of Notes Receivable from Related Parties USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-07-21 0001640334-23-001347
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-21 0001640334-22-002503
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-07-24 0001640334-25-001300
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 2.52M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001640334-22-001037
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -32.82M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 298,500 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-21 0001640334-22-002503
us-gaap Revenues Revenues USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap SecurityDeposit Security Deposit USD 0 2025-12-31 2025 FY 10-K 2026-02-11 0001640334-26-000241
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 77,825 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-07-24 0001640334-25-001300
us-gaap SharePrice Share Price USD/shares 1 2017-09-30 2018 FY 10-K 2018-12-28 0001640334-18-002423
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0.005 2015-09-30 2016 FY 10-K 2016-12-16 0001640334-16-002238
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -444,789 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 2 2017-05-01 2017-05-18 2018 FY 10-K 2018-12-28 0001640334-18-002423
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 500,000 2016-10-01 2017-09-30 2017 FY 10-K/A 2018-01-16 0001640334-18-000103
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 804,650 2021-04-01 2021-06-30 2022 Q2 10-Q 2022-08-12 0001640334-22-001752
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 500,000 2016-10-01 2017-09-30 2018 FY 10-K 2018-12-28 0001640334-18-002423
us-gaap TimeDepositsAtOrAboveFDICInsuranceLimit Time Deposits, at or Above FDIC Insurance Limit USD 250,000 2025-12-31 2025 FY 10-K 2026-02-11 0001640334-26-000241
us-gaap UtilitiesOperatingExpenseTaxes Utilities Operating Expense, Taxes USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001640334-22-000809
us-gaap ValuationAllowancesAndReservesAdjustments SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment USD 1.85M 2023-01-01 2023-12-31 2023 FY 10-K 2025-07-18 0001640334-25-001245
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 60.04M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001640334-26-001345
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 51.75M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001640334-21-002942

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →